Lactose (India)

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE058I01013
NSEID:
BSEID: 524202

INR

107.00

2 (1.9%)

BSENSE

Apr 11, 12:41 PM

BSE+NSE Vol: 43

{
  "main_header": {
    "sid": 469912,
    "name": "Lactose (India)",
    "stock_name": "Lactose (India)",
    "full_name": "Lactose (India) Ltd",
    "name_url": "stocks-analysis/lactose-india",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "107.00",
    "chg": 2,
    "chgp": "1.9%",
    "dir": 1,
    "prev_price": "105.00",
    "mcapval": "148.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524202,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE058I01013",
    "curr_date": "Apr 11, 12:41 PM",
    "curr_time": "00:19 AM",
    "bse_nse_vol": "43 ",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lactose-india-469912-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Lactose (India) Ltd Achieves 5% Gain Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-ltd-surges-5-00-today-marking-10-05-weekly-gain-amid-sensex-decline-1694682",
        "imagepath": "",
        "date": "2025-04-03 09:55:07",
        "description": "Lactose (India) Ltd is currently witnessing significant buying activity, with the stock rising by 5.00% today, contrasting sharply with the Sensex's decline of 0.43%. Over the past week, Lactose has shown a robust performance, gaining 10.05%, while the Sensex fell by 1.70%. Notably, the stock has experienced consecutive gains for three days, accumulating a total return of 13.42% during this period.\n\nToday, Lactose opened with a gap up of 4.06% and reached an intraday high of Rs 101. The stock has maintained this price level throughout the trading session. Despite its recent gains, Lactose's performance over the past month shows a decline of 5.07%, while the Sensex has increased by 4.39%. \n\nIn terms of moving averages, Lactose is currently above its 5-day moving average but below the 20-day, 50-day, 100-day, and 200-day moving averages. The Pharmaceuticals & Drugs sector has also seen positive momentum, gain..."
      },
      {
        "title": "Lactose (India) Ltd Sees Strong Buying Activity Amid Ongoing Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-ltd-surges-4-22-today-marking-second-consecutive-day-of-gains-1674794",
        "imagepath": "",
        "date": "2025-04-02 11:35:06",
        "description": "Lactose (India) Ltd is currently witnessing strong buying activity, with the stock gaining 4.22% today, significantly outperforming the Sensex, which rose by only 0.55%. This marks the second consecutive day of gains for Lactose, with a total increase of 6.01% over this period. Despite this recent uptick, the stock has faced challenges over the longer term, with a 54.56% decline over the past three months and a year-to-date drop of 55.04%.\n\nThe stock opened with a gap up, reflecting positive market sentiment, although it did experience an intraday low of Rs 91, down 2.29%. Lactose's performance relative to the Sensex has been mixed, with notable declines over the past month and year, contrasting with the broader market's gains. \n\nSeveral factors may be contributing to the current buying pressure, including potential market corrections or sector-specific developments within the pharmaceuticals and drugs indu..."
      },
      {
        "title": "Lactose (India) Ltd Sees Significant Buying Activity Amid Market Decline, Reverses Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-ltd-surges-4-58-today-reaching-intraday-high-of-rs-93-13-amid-market-decline-1664697",
        "imagepath": "",
        "date": "2025-04-01 15:35:05",
        "description": "Lactose (India) Ltd is witnessing significant buying activity today, with the stock rising by 4.58%, contrasting sharply with the Sensex, which has declined by 1.80%. This uptick marks a trend reversal after three consecutive days of declines. The stock reached an intraday high of Rs 93.13, although it also hit a new 52-week low of Rs 84.27 during the trading session.\n\nOver the past week, Lactose (India) has experienced a decline of 6.87%, while the Sensex fell by 2.55%. In the longer term, the stock has faced challenges, with a 58.24% drop over the past three months and a year-to-date decline of 56.86%. However, it has shown resilience over a three-year period, gaining 58.12%, and an impressive 467.87% over the past five years, significantly outperforming the Sensex.\n\nThe current buying pressure may be attributed to various factors, including market sentiment and potential recovery signals after recent low..."
      },
      {
        "title": "Lactose (India) Faces Financial Struggles Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-stock-hits-52-week-low-amid-broader-market-decline-1660674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/LactoseIndia_priceRelatedfactors_852826.png",
        "date": "2025-04-01 11:47:24",
        "description": "Lactose (India), a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low amid a 38.14% annual decline. The company's financial results show a drop in net sales and low return on capital, compounded by a high debt-to-EBITDA ratio, indicating ongoing market challenges."
      },
      {
        "title": "Lactose (India) Hits 52-Week Low Amid Broader Market Decline and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-hits-52-week-low-amid-broader-market-decline-and-weak-fundamentals-1660669",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/LactoseIndia_priceRelatedfactors_852829.png",
        "date": "2025-04-01 11:47:23",
        "description": "Lactose (India), a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low amid a broader market decline. Despite a challenging year with a 38.14% drop, the company outperformed its sector today. Financial metrics indicate weak long-term fundamentals and declining sales performance."
      },
      {
        "title": "Lactose (India) Faces Financial Struggles Amid Significant Stock Volatility and Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-hits-52-week-low-amid-ongoing-financial-struggles-and-market-decline-1639063",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LactoseIndia_priceRelatedfactors_832652.png",
        "date": "2025-03-28 09:45:36",
        "description": "Lactose (India), a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid ongoing volatility. The stock has underperformed its sector significantly, with a notable decline over the past year and concerning financial metrics, including a low Return on Capital Employed and high Debt to EBITDA ratio."
      },
      {
        "title": "Lactose (India) Faces Ongoing Challenges Amid Significant Stock Volatility and Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-hits-52-week-low-amid-ongoing-stock-decline-and-poor-performance-1639059",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LactoseIndia_priceRelatedfactors_832654.png",
        "date": "2025-03-28 09:45:32",
        "description": "Lactose (India), a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, reaching a new 52-week low. The stock has underperformed its sector and recorded a notable decline over the past year, with concerning financial metrics and a bearish technical outlook."
      },
      {
        "title": "Lactose (India) Faces Operational Challenges Amidst Continued Stock Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-stock-hits-52-week-low-amid-ongoing-decline-and-sales-drop-1639061",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LactoseIndia_priceRelatedfactors_832653.png",
        "date": "2025-03-28 09:45:32",
        "description": "Lactose (India), a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low amid ongoing challenges, including a decline in net sales and consecutive quarterly losses. The stock's performance has lagged significantly behind the broader market, reflecting weak fundamentals and a bearish technical trend."
      },
      {
        "title": "Lactose (India) Faces Continued Volatility Amid Weak Financial Performance and Sector Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-stock-hits-52-week-low-amid-continued-financial-struggles-2-1625520",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LactoseIndia_priceRelatedfactors_819838.png",
        "date": "2025-03-27 12:05:59",
        "description": "Lactose (India), a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, reaching a 52-week low. The company has reported declining net sales and six consecutive quarters of negative results, with a low operating profit to interest ratio and modest return on capital employed, reflecting ongoing challenges."
      }
    ],
    "total": 74,
    "sid": "469912",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/lactose-india-469912"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "28-Mar-2025",
      "details": "We hereby submit the intimation towards the closure of trading window for the fourth quarter and year ended 31st March 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Feb-2025",
      "details": "Pursuant to Regulation 30 & 47(3) of SEBI (LODR) Regulations 2015 we hereby submit the newspaper publication of financial results for the quarter ended 31st December 2024.",
      "source": "BSE"
    },
    {
      "caption": "Integrated Filing (Financial)",
      "datetime": "12-Feb-2025",
      "details": "In compliance with SEBI Circular dated 31st December 2024 we hereby submit the Integrated Financials filing of the Company for the aforesaid period.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lactose (India) Ltd Achieves 5% Gain Amid Broader Market Decline

2025-04-03 09:55:07

Lactose (India) Ltd is currently witnessing significant buying activity, with the stock rising by 5.00% today, contrasting sharply with the Sensex's decline of 0.43%. Over the past week, Lactose has shown a robust performance, gaining 10.05%, while the Sensex fell by 1.70%. Notably, the stock has experienced consecutive gains for three days, accumulating a total return of 13.42% during this period. Today, Lactose opened with a gap up of 4.06% and reached an intraday high of Rs 101. The stock has maintained this price level throughout the trading session. Despite its recent gains, Lactose's performance over the past month shows a decline of 5.07%, while the Sensex has increased by 4.39%. In terms of moving averages, Lactose is currently above its 5-day moving average but below the 20-day, 50-day, 100-day, and 200-day moving averages. The Pharmaceuticals & Drugs sector has also seen positive momentum, gain...

Lactose (India) Ltd Sees Strong Buying Activity Amid Ongoing Volatility

2025-04-02 11:35:06

Lactose (India) Ltd is currently witnessing strong buying activity, with the stock gaining 4.22% today, significantly outperforming the Sensex, which rose by only 0.55%. This marks the second consecutive day of gains for Lactose, with a total increase of 6.01% over this period. Despite this recent uptick, the stock has faced challenges over the longer term, with a 54.56% decline over the past three months and a year-to-date drop of 55.04%. The stock opened with a gap up, reflecting positive market sentiment, although it did experience an intraday low of Rs 91, down 2.29%. Lactose's performance relative to the Sensex has been mixed, with notable declines over the past month and year, contrasting with the broader market's gains. Several factors may be contributing to the current buying pressure, including potential market corrections or sector-specific developments within the pharmaceuticals and drugs indu...

Lactose (India) Ltd Sees Significant Buying Activity Amid Market Decline, Reverses Trend

2025-04-01 15:35:05

Lactose (India) Ltd is witnessing significant buying activity today, with the stock rising by 4.58%, contrasting sharply with the Sensex, which has declined by 1.80%. This uptick marks a trend reversal after three consecutive days of declines. The stock reached an intraday high of Rs 93.13, although it also hit a new 52-week low of Rs 84.27 during the trading session. Over the past week, Lactose (India) has experienced a decline of 6.87%, while the Sensex fell by 2.55%. In the longer term, the stock has faced challenges, with a 58.24% drop over the past three months and a year-to-date decline of 56.86%. However, it has shown resilience over a three-year period, gaining 58.12%, and an impressive 467.87% over the past five years, significantly outperforming the Sensex. The current buying pressure may be attributed to various factors, including market sentiment and potential recovery signals after recent low...

Lactose (India) Faces Financial Struggles Amid Broader Market Decline

2025-04-01 11:47:24

Lactose (India), a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low amid a 38.14% annual decline. The company's financial results show a drop in net sales and low return on capital, compounded by a high debt-to-EBITDA ratio, indicating ongoing market challenges.

Lactose (India) Hits 52-Week Low Amid Broader Market Decline and Weak Fundamentals

2025-04-01 11:47:23

Lactose (India), a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low amid a broader market decline. Despite a challenging year with a 38.14% drop, the company outperformed its sector today. Financial metrics indicate weak long-term fundamentals and declining sales performance.

Lactose (India) Faces Financial Struggles Amid Significant Stock Volatility and Decline

2025-03-28 09:45:36

Lactose (India), a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid ongoing volatility. The stock has underperformed its sector significantly, with a notable decline over the past year and concerning financial metrics, including a low Return on Capital Employed and high Debt to EBITDA ratio.

Lactose (India) Faces Ongoing Challenges Amid Significant Stock Volatility and Decline

2025-03-28 09:45:32

Lactose (India), a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, reaching a new 52-week low. The stock has underperformed its sector and recorded a notable decline over the past year, with concerning financial metrics and a bearish technical outlook.

Lactose (India) Faces Operational Challenges Amidst Continued Stock Decline

2025-03-28 09:45:32

Lactose (India), a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low amid ongoing challenges, including a decline in net sales and consecutive quarterly losses. The stock's performance has lagged significantly behind the broader market, reflecting weak fundamentals and a bearish technical trend.

Lactose (India) Faces Continued Volatility Amid Weak Financial Performance and Sector Underperformance

2025-03-27 12:05:59

Lactose (India), a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, reaching a 52-week low. The company has reported declining net sales and six consecutive quarters of negative results, with a low operating profit to interest ratio and modest return on capital employed, reflecting ongoing challenges.

View All News

Announcement

Closure of Trading Window

28-Mar-2025 | Source : BSE

We hereby submit the intimation towards the closure of trading window for the fourth quarter and year ended 31st March 2025.

Announcement under Regulation 30 (LODR)-Newspaper Publication

13-Feb-2025 | Source : BSE

Pursuant to Regulation 30 & 47(3) of SEBI (LODR) Regulations 2015 we hereby submit the newspaper publication of financial results for the quarter ended 31st December 2024.